Hester Bios

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE782E01017
NSEID: HESTERBIO
BSEID: 524669
View on NSE | View on BSE

INR

2,417.90

-40.6 (-1.65%)

BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 6.15 k

{
  "main_header": {
    "sid": 324228,
    "name": "Hester Bios",
    "stock_name": "Hester Bios",
    "full_name": "Hester Biosciences Ltd",
    "name_url": "stocks-analysis/hester-bios",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,417.90",
    "chg": -40.6,
    "chgp": "-1.65%",
    "dir": -1,
    "prev_price": "2,458.50",
    "mcapval": "2,092.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524669,
    "symbol": "HESTERBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE782E01017",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "02:24 AM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "6.15 k",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hester-bios-324228-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Hester Biosciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-sell-4133414",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/HesterBioscienc_mojoScore_4133414.png",
        "date": "2026-08-03 10:11:08",
        "description": "Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 August 2026, providing investors with the most up-to-date insight into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Hester Biosciences Gains 4.97%: 3 Key Factors Driving the Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-gains-497-3-key-factors-driving-the-weeks-volatility-4132140",
        "imagepath": "",
        "date": "2026-08-02 09:01:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jul:</strong> Stock surges 6.94% to Rs.2,528.50 on strong buying interest</p>\n                    <p><strong>30 Jul:</strong> Hits new 52-week high at Rs.2,669 before closing lower amid mixed quarterly results</p>\n                    <p><strong>31 Jul:</strong> Recovers modestly, closing at Rs.2,482.05 (+0.84%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,364.50</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.2,482.05</div><div class=\"stat-change positive\">+4.97%</div></div..."
      },
      {
        "title": "Are Hester Biosciences Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-hester-biosciences-ltd-latest-results-good-or-bad-4129039",
        "imagepath": "",
        "date": "2026-07-30 19:19:53",
        "description": "Hester Biosciences Ltd's latest financial results for Q1 FY27 present a complex picture of the company's performance. The net profit reported was ₹96.98 crores, reflecting a substantial year-on-year growth of 489.90%. However, this impressive profit figure is accompanied by a concerning decline in net sales, which totaled ₹77.24 crores, representing an 8.17% decrease compared to the same quarter last year. This decline raises questions about the company's revenue generation capabilities and potential market challenges.\n\nThe operating margin, excluding other income, stood at 29.48%, which shows a slight improvement from the previous year. This indicates that the company has managed to maintain its operating profitability despite the drop in sales, suggesting effective cost management. However, the sequential decline in sales of 22.84% from the previous quarter indicates potential operational challenges that ..."
      },
      {
        "title": "Hester Biosciences Q1 FY27: Exceptional Profit Surge Masks Revenue Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/hester-biosciences-q1-fy27-exceptional-profit-surge-masks-revenue-concerns-4129003",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/HesterBioscienc_quaterlyResult_4129003.png",
        "date": "2026-07-30 17:02:41",
        "description": "Hester Biosciences Ltd., one of India's pioneering animal healthcare companies, has reported a remarkable 489.90% year-on-year surge in consolidated net profit to ₹96.98 crores for Q1 FY27, driven by an extraordinary one-time gain that inflated pre-tax profit to ₹101.68 crores. However, the underlying operational picture reveals concerning trends, with net sales declining 8.17% year-on-year to ₹77.24 crores and falling 22.84% sequentially from Q4 FY26's ₹100.11 crores. The stock, currently trading at ₹2,461.35 with a market capitalisation of ₹2,137 crores, has declined 1.30% following the results announcement, reflecting investor scepticism about the sustainability of this profit performance."
      },
      {
        "title": "Hester Biosciences Ltd Reports Flat Quarterly Performance Amid Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-reports-flat-quarterly-performance-amid-margin-pressures-4128901",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/HesterBioscienc_fintrenddot_4128901.png",
        "date": "2026-07-30 15:00:06",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended June 2026, signalling a notable shift from its previously positive growth trajectory. Despite robust profit after tax growth and strong return on capital employed, the company faces headwinds from declining sales and margin contraction, prompting a downgrade in its Mojo Grade from Hold to Sell."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Hester Biosciences Ltd to 52-Week High of Rs 2669",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-hits-new-52-week-high-at-rs2669-4128767",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/HesterBioscienc_priceRelatedfactors_4128767.png",
        "date": "2026-07-30 12:10:26",
        "description": "Surging past its previous peaks, Hester Biosciences Ltd touched a fresh 52-week high of Rs 2669 on 30 Jul 2026, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and a market environment where the Sensex trades near its own highs."
      },
      {
        "title": "When is the next results date for Hester Biosciences Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-hester-biosciences-ltd-4119880",
        "imagepath": "",
        "date": "2026-07-24 23:17:06",
        "description": "The next results date for Hester Biosciences Ltd is scheduled for 30 July 2026...."
      },
      {
        "title": "Hester Biosciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-hold-4117519",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/HesterBioscienc_mojoScore_4117519.png",
        "date": "2026-07-23 10:11:14",
        "description": "Hester Biosciences Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 08 June 2026. While this rating change occurred in early June, the analysis and financial metrics discussed here reflect the company’s current position as of 23 July 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Hester Biosciences Gains 15.92%: 3 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-gains-1592-3-key-factors-driving-the-weeks-momentum-4107796",
        "imagepath": "",
        "date": "2026-07-19 09:00:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>13 Jul:</strong> Upper circuit hit with 20% surge to Rs.2,545</p>\n                    <p><strong>14 Jul:</strong> New 52-week high at Rs.2,661.65</p>\n                    <p><strong>15-17 Jul:</strong> Steady gains with positive technical signals</p>\n                    <p><strong>17 Jul:</strong> Week closes at Rs.2,445.15 (+15.92%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,109.40</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.2,445.15</div><div class=\"stat-change positive..."
      }
    ],
    "total": 5496,
    "sid": "324228",
    "stock_news_url": "https://www.marketsmojo.com/news/hester-biosciences-324228"
  },
  "announcements": [
    {
      "details": "Hester Biosciences Limited has informed the Exchange regarding Board meeting held on November 06, 2019.",
      "source": "NSE",
      "caption": "Hester Biosciences Limited - Outcome of Board Meeting",
      "datetime": "06-Nov-2019"
    },
    {
      "details": "Hester Biosciences Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Hester Biosciences Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "31-Oct-2019"
    },
    {
      "details": " <table><tr><td>There is Discrepancies in earlier filed Voting Results. So we have rectified the error and uploaded revised file. </td></tr></table>",
      "source": "NSE",
      "caption": "Shareholders meeting",
      "datetime": "05-Aug-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has declared <strong>110%</strong> dividend, ex-date: 14 Jul 26",
          "dt": "2026-07-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 27 Sep 12",
          "dt": "2012-09-27",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>2:5</strong> rights issue, ex-date: 29 May 06",
          "dt": "2006-05-29",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Hester Biosciences Ltd is Rated Sell

2026-08-03 10:11:08

Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 August 2026, providing investors with the most up-to-date insight into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Hester Biosciences Gains 4.97%: 3 Key Factors Driving the Week’s Volatility

2026-08-02 09:01:08

Key Events This Week

27 Jul: Stock surges 6.94% to Rs.2,528.50 on strong buying interest

30 Jul: Hits new 52-week high at Rs.2,669 before closing lower amid mixed quarterly results

31 Jul: Recovers modestly, closing at Rs.2,482.05 (+0.84%)

Read full news article

Are Hester Biosciences Ltd latest results good or bad?

2026-07-30 19:19:53

Hester Biosciences Ltd's latest financial results for Q1 FY27 present a complex picture of the company's performance. The net profit reported was ₹96.98 crores, reflecting a substantial year-on-year growth of 489.90%. However, this impressive profit figure is accompanied by a concerning decline in net sales, which totaled ₹77.24 crores, representing an 8.17% decrease compared to the same quarter last year. This decline raises questions about the company's revenue generation capabilities and potential market challenges. The operating margin, excluding other income, stood at 29.48%, which shows a slight improvement from the previous year. This indicates that the company has managed to maintain its operating profitability despite the drop in sales, suggesting effective cost management. However, the sequential decline in sales of 22.84% from the previous quarter indicates potential operational challenges that ...

Read full news article

Hester Biosciences Q1 FY27: Exceptional Profit Surge Masks Revenue Concerns

2026-07-30 17:02:41

Hester Biosciences Ltd., one of India's pioneering animal healthcare companies, has reported a remarkable 489.90% year-on-year surge in consolidated net profit to ₹96.98 crores for Q1 FY27, driven by an extraordinary one-time gain that inflated pre-tax profit to ₹101.68 crores. However, the underlying operational picture reveals concerning trends, with net sales declining 8.17% year-on-year to ₹77.24 crores and falling 22.84% sequentially from Q4 FY26's ₹100.11 crores. The stock, currently trading at ₹2,461.35 with a market capitalisation of ₹2,137 crores, has declined 1.30% following the results announcement, reflecting investor scepticism about the sustainability of this profit performance.

Read full news article

Hester Biosciences Ltd Reports Flat Quarterly Performance Amid Margin Pressures

2026-07-30 15:00:06

Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended June 2026, signalling a notable shift from its previously positive growth trajectory. Despite robust profit after tax growth and strong return on capital employed, the company faces headwinds from declining sales and margin contraction, prompting a downgrade in its Mojo Grade from Hold to Sell.

Read full news article

Broad-Based Technical Strength Lifts Hester Biosciences Ltd to 52-Week High of Rs 2669

2026-07-30 12:10:26

Surging past its previous peaks, Hester Biosciences Ltd touched a fresh 52-week high of Rs 2669 on 30 Jul 2026, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and a market environment where the Sensex trades near its own highs.

Read full news article

When is the next results date for Hester Biosciences Ltd?

2026-07-24 23:17:06

The next results date for Hester Biosciences Ltd is scheduled for 30 July 2026....

Read full news article

Hester Biosciences Ltd is Rated Hold

2026-07-23 10:11:14

Hester Biosciences Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 08 June 2026. While this rating change occurred in early June, the analysis and financial metrics discussed here reflect the company’s current position as of 23 July 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and technical outlook.